Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Perumattam

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1996
Novel anti-inflammatory compounds prevent CD11b/CD18, alpha M beta 2 (Mac-1)-dependent neutrophil adhesion without blocking activation-induced changes in Mac-1G Endemann, Y Feng, C M Bryant, et al.
Molecular Diversity|January 1, 1997
Solid phase synthesis of combinatorial libraries using anhydrides as templatesJ Perumattam, S Chakravarty, G A McEnroe, et al.
Journal of Medicinal Chemistry|August 2, 1996
Synthesis and characterization of pseudopeptide bradykinin B2 receptor antagonists containing the 1,3,8-triazaspiro[4.5]decan-4-one ring systemB J Mavunkel, Z Lu, R R Goehring, et al.
Journal of Medicinal Chemistry|May 12, 1995
Fluorenylalkanoic and benzoic acids as novel inhibitors of cell adhesion processes in leukocytesG S Hamilton, R E Mewshaw, C M Bryant, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Indole-based heterocyclic inhibitors of p38alpha MAP kinase: designing a conformationally restricted analogueBabu J Mavunkel, Sarvajit Chakravarty, John J Perumattam, et al.
Bioorganic & Medicinal Chemistry Letters|December 25, 2009
Piperidine-based heterocyclic oxalyl amides as potent p38 alpha MAP kinase inhibitorsBabu J Mavunkel, John J Perumattam, Xuefei Tan, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2010
Design and synthesis of piperazine-indole p38 alpha MAP kinase inhibitors with improved pharmacokinetic profilesXuefei Tan, Richland W Tester, Gregory R Luedtke, et al.
Leukemia|April 18, 2006
Inhibition of p38alpha MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-X(L), Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivoT A Navas, A N Nguyen, T Hideshima, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1996
Novel anti-inflammatory compounds prevent CD11b/CD18, alpha M beta 2 (Mac-1)-dependent neutrophil adhesion without blocking activation-induced changes in Mac-1G Endemann, Y Feng, C M Bryant, et al.
Molecular Diversity|January 1, 1997
Solid phase synthesis of combinatorial libraries using anhydrides as templatesJ Perumattam, S Chakravarty, G A McEnroe, et al.
Journal of Medicinal Chemistry|August 2, 1996
Synthesis and characterization of pseudopeptide bradykinin B2 receptor antagonists containing the 1,3,8-triazaspiro[4.5]decan-4-one ring systemB J Mavunkel, Z Lu, R R Goehring, et al.
Journal of Medicinal Chemistry|May 12, 1995
Fluorenylalkanoic and benzoic acids as novel inhibitors of cell adhesion processes in leukocytesG S Hamilton, R E Mewshaw, C M Bryant, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Indole-based heterocyclic inhibitors of p38alpha MAP kinase: designing a conformationally restricted analogueBabu J Mavunkel, Sarvajit Chakravarty, John J Perumattam, et al.
Bioorganic & Medicinal Chemistry Letters|December 25, 2009
Piperidine-based heterocyclic oxalyl amides as potent p38 alpha MAP kinase inhibitorsBabu J Mavunkel, John J Perumattam, Xuefei Tan, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2010
Design and synthesis of piperazine-indole p38 alpha MAP kinase inhibitors with improved pharmacokinetic profilesXuefei Tan, Richland W Tester, Gregory R Luedtke, et al.
Leukemia|April 18, 2006
Inhibition of p38alpha MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-X(L), Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivoT A Navas, A N Nguyen, T Hideshima, et al.
Pageof 1